| 000 | 01249 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250511180025.0 | ||
| 264 | 0 | _c19920609 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKruppa, G | |
| 245 | 0 | 0 |
_aInhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cMay 1992 |
||
| 300 |
_a3152-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aHIV Long Terminal Repeat |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aNF-kappa B _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aThoma, B | |
| 700 | 1 | _aMachleidt, T | |
| 700 | 1 | _aWiegmann, K | |
| 700 | 1 | _aKrönke, M | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 148 _gno. 10 _gp. 3152-7 |
|
| 999 |
_c1322353 _d1322353 |
||